A detailed history of Quest Partners LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 15,112 shares of KALV stock, worth $172,427. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,112
Holding current value
$172,427
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$9.46 - $15.39 $142,959 - $232,573
15,112 New
15,112 $175 Million
Q1 2024

May 09, 2024

BUY
$11.07 - $16.04 $19,926 - $28,872
1,800 New
1,800 $21.3 Million

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $281M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.